Mingkun Yu | Cancer Cell Biology | Best Researcher Award

Posted on by sciencefather

Dr. Mingkun Yu | Cancer Cell Biology | Best Researcher Award

Dr. Mingkun Yu , Binzhou Medical College Affiliated Traditional Chinese Medicine Hospital(Binzhou Traditional Chinese Medicine Hospital) , China

Dr. Mingkun Yu is an Associate Chief Physician at Binzhou Traditional Chinese Medicine Hospital, affiliated with Binzhou Medical College, China. He is an expert in integrating evidence-based medicine with traditional Chinese and Western medical practices, especially within oncology and ophthalmology. With over five years of clinical experience, Dr. Yu has made significant contributions to the field through impactful clinical research, trial designs, and methodological innovation. He is the recipient of a National Natural Science Foundation of China project and has led the development of national-level guidelines. Dr. Yu’s publications have gained high visibility, with citations and downloads from prestigious journals like BMJ. He collaborates with renowned experts worldwide and actively contributes as a peer reviewer for SCI journals. Known for his meticulous clinical approach and research rigor, Dr. Yu is a rising star in integrative medical science, particularly in addressing patient compliance and advancing myopia-related research strategies.

Publication Profile:

Orcid

✅ Strengths for the Award:

  1. Academic Excellence
    Dr. Yu has earned advanced degrees from top-tier traditional Chinese medicine institutions in China, culminating in a PhD focused on integrated clinical medicine—a rare and interdisciplinary specialty.

  2. Proven Research Record

    • Published 7 SCI-indexed papers (including in BMJ and Therapeutic Advances in Gastroenterology) and 5 Chinese core journal papers.

    • First/corresponding author impact factor: 18.3; co-author cumulative impact factor: 112.

    • One article with 9248 downloads, another cited 66 times—demonstrating strong academic reach and relevance.

  3. Research Leadership

    • Designed and led multiple RCTs, cohort studies, and cluster RCTs.

    • Principal investigator of a National Natural Science Foundation of China project.

    • Spearheaded the national-level guideline on myopia—a major public health concern in Asia.

  4. Innovative Contributions

    • Introduced target value analysis and conducted extensive patient compliance research in clinical trials.

    • Integrated evidence-based methods with traditional Chinese medicine, a cutting-edge niche in global medical research.

  5. Collaborations & Peer Review

    • Collaborates with global leaders such as Paul Little, Gordon Guyatt, and Lehana Thabane.

    • Reviewer for top SCI journals including European Journal of Integrative Medicine and BMC Geriatrics.

⚙️ Areas for Improvement:

  1. Global Dissemination & Outreach

    • Dr. Yu could further enhance his profile by increasing international speaking engagements, attending more global medical symposia, and joining international research societies.

  2. Books or Monographs

    • No books published yet. Authoring clinical reference books or practitioner guides would boost both practical impact and professional visibility.

  3. Translational Research and Patents

    • With only one published patent, there is scope to convert more research findings into innovative tools, treatments, or technologies for broader clinical application.

  4. Professional Memberships

    • Active memberships in professional research or clinical bodies could enhance his professional network and visibility in award circuits.

📚 Education:

Dr. Yu earned his Master’s degree in Evidence-Based Medicine (Oncology) from Beijing University of Traditional Chinese Medicine in 2021. His academic journey culminated in a PhD in Clinical Medicine (Integrated Traditional Chinese and Western Medicine) from Shandong University of Traditional Chinese Medicine in 2024. Throughout his education, Dr. Yu focused on bridging the gap between traditional Chinese therapeutic principles and contemporary Western medical methodologies. His doctoral research emphasized designing clinical trials, evaluating treatment efficacy using systematic review and meta-analysis, and developing methodologies for improving patient outcomes. His educational background also provided him with comprehensive knowledge in oncology, ophthalmology, acupuncture, and behavioral health, preparing him to implement innovative, integrative solutions in clinical practice. He was mentored by leading figures in evidence-based medicine and engaged in collaborative studies with international researchers, further enriching his global research perspective.

🩺 Experience:

With more than 5 years of experience in clinical medicine, Dr. Mingkun Yu has become a prominent practitioner and researcher in integrated traditional Chinese and Western medical care. As an Associate Chief Physician at Binzhou Traditional Chinese Medicine Hospital, he leads and participates in high-level clinical research projects, including randomized controlled trials and cohort studies. He has contributed to over 7 national-level research projects and served as principal investigator in hospital-based clinical studies. Dr. Yu’s areas of expertise include patient compliance strategies in oncology, evidence synthesis in myopia prevention, and methodological development for clinical trials. He is a frequent presenter at national and international conferences and has served as a reviewer for SCI-indexed journals. Dr. Yu is also involved in writing clinical practice guidelines and has been recognized for his scientific contributions through research awards and publications in high-impact journals.

🔬 Research Focus:

Dr. Mingkun Yu’s research lies at the intersection of evidence-based medicine and integrated Chinese and Western clinical practices. His key focus areas include patient compliance in oncology, risk factor identification and prevention strategies for myopia, and designing robust clinical trials like RCTs, cohort, and cluster studies. He actively develops and applies systematic review methodologies, meta-analyses, and guideline development processes to ensure high-impact clinical outcomes. Dr. Yu has innovated in the area of patient compliance by applying qualitative synthesis and target value analysis, improving retention and adherence in clinical trials. He is particularly invested in the development of guidelines for myopia in children and adolescents and has published widely in SCI journals. His collaboration with global experts such as Paul Little, Gordon Guyatt, and Lehana Thabane strengthens the international relevance of his work. Through this multifaceted research approach, Dr. Yu aims to bridge traditional wisdom with modern scientific rigor.

📝 Publications Top Notes:

📄 Pseudomyopia as an independent risk factor for myopia onset: a prospective cohort study among school-aged children – British Journal of Ophthalmology, 2024
📘 The Process factors and improvement strategies of patient compliance and retention in clinical trials: a synthesis of qualitative research – Inplasy Report, 2021
📚 Berberine for diarrhea in children and adults: a systematic review and meta-analysis – Therapeutic Advances in Gastroenterology, 2020

🧾 Conclusion:

Dr. Mingkun Yu stands out as a highly deserving candidate for the Best Researcher Award due to his cross-disciplinary research integrating traditional Chinese and Western medicine, his leadership in national clinical trials, impactful publications, and commitment to clinical innovation. His scholarly output is not only substantial but also highly cited and widely read, reflecting real-world influence and academic excellence.

With a growing international research presence, a unique focus on culturally integrated methodologies, and an impressive trajectory of innovation and collaboration, Dr. Yu clearly embodies the ideals of a next-generation clinical research leader.

Paola Zagami | Cancer Cell Biology | Young Scientist Award

Posted on by sciencefather

Dr. Paola Zagami | Cancer Cell Biology | Young Scientist Award

Dr. Paola Zagami , IEO european institute of oncology University of Milan , Italy

Dr. Paola Zagami is an accomplished Italian physician and medical oncologist currently working at the European Institute of Oncology (IEO) in Milan. She specializes in clinical and research oncology, focusing on breast cancer. With a strong academic background and passion for advancing cancer treatment, Dr. Zagami has contributed to numerous studies on innovative therapies, particularly immunotherapy and endocrine treatments in breast cancer. She is recognized for her expertise in cancer genomics and the impact of immune checkpoint inhibitors in cancer treatment. Dr. Zagami’s work reflects a blend of clinical practice and research, as she actively collaborates with experts in the oncology field to improve patient outcomes.

Publication Profile:

Scopus

Strengths for the Award:

Dr. Paola Zagami is an exceptional candidate for the Research for Young Scientist Award due to her profound contributions to oncology research, particularly in breast cancer treatment and clinical trials. Her work on immune checkpoint inhibitors, endocrine therapies, and the genomics of breast cancer demonstrates her expertise in precision oncology. Dr. Zagami has been involved in high-impact publications and collaborative international studies, such as her work on metastatic triple-negative breast cancer and the development of novel cancer therapies. Her clinical and research skills, combined with her ability to contribute to the scientific community through publications and awards, make her a highly qualified and promising young scientist. Furthermore, her commitment to gender equity in pharmacological research and clinical trials aligns with the future direction of oncology research, making her a strong contender for the award.

Areas for Improvement:

While Dr. Zagami has made significant strides in breast cancer research, there are opportunities to broaden her research focus to include other cancer types, enabling her to contribute to a wider array of oncological studies. Additionally, further involvement in leading large-scale clinical trials could enhance her leadership in the field. Expanding her research network internationally could facilitate more diverse collaborations and broader research impact.

Education:

Dr. Zagami earned her medical degree (MD) and has since pursued extensive education in the field of oncology. In 2021, she received a scholarship from the IEO-Monzino Foundation, focusing on clinical research in oncology. She further honed her expertise by earning the AMMI award in 2023 for her work on gender equity in pharmacological research. This education in clinical research positions Dr. Zagami as a thought leader in her field, with a commitment to investigating new treatments and approaches in cancer care.

Experience:

Dr. Zagami’s professional career began as an oncological clinical researcher, where she focused on the development of targeted therapies and the clinical impact of cancer treatments. Since 2024, she has been serving as a medical oncologist at the European Institute of Oncology (IEO) in Milan, contributing to both clinical and research activities. Throughout her career, Dr. Zagami has gained experience in advanced oncology treatments, particularly in immunotherapy and endocrine therapies for breast cancer. She works closely with interdisciplinary teams to design and conduct clinical trials, improving personalized cancer care. Dr. Zagami’s research collaborations have resulted in several publications in prestigious journals, reflecting her expertise and commitment to enhancing cancer treatment strategies.

Experience:

Dr. Zagami’s professional career began as an oncological clinical researcher, where she focused on the development of targeted therapies and the clinical impact of cancer treatments. Since 2024, she has been serving as a medical oncologist at the European Institute of Oncology (IEO) in Milan, contributing to both clinical and research activities. Throughout her career, Dr. Zagami has gained experience in advanced oncology treatments, particularly in immunotherapy and endocrine therapies for breast cancer. She works closely with interdisciplinary teams to design and conduct clinical trials, improving personalized cancer care. Dr. Zagami’s research collaborations have resulted in several publications in prestigious journals, reflecting her expertise and commitment to enhancing cancer treatment strategies.

Research Focus:

Dr. Zagami’s research focus is primarily centered around the treatment of breast cancer, particularly in the areas of immunotherapy, endocrine therapy, and personalized medicine. She has been involved in research on immune checkpoint inhibitors for metastatic triple-negative breast cancer and the clinical implications of genomic alterations in breast cancer. Dr. Zagami is also dedicated to investigating the safety and efficacy of novel cancer therapies, particularly in early-phase clinical trials. Her research interests also include the study of gender equity in pharmacological research and the integration of molecular diagnostics in clinical trials for metastatic breast cancer. She is committed to advancing precision oncology by studying the genetic and clinical landscape of breast cancer to enhance patient outcomes and treatment strategies.

Publications Top Notes:

  1. Immunotherapy in the treatment landscape of hormone receptor-positive (HR+) early breast cancer: is new data clinical practice changing?
  2. Triple negative breast cancer: pitfalls and progress.
  3. Association of PIK3CA Mutation With Pathologic Complete Response and Outcome by Hormone Receptor Status and Intrinsic Subtype in Early-Stage ERBB2/HER2-Positive Breast Cancer.
  4. Endocrine therapy for early breast cancer in the era of oral selective estrogen receptor degraders: challenges and future perspectives.
  5. Effect of age on safety and efficacy of novel cancer drugs investigated in early-phase clinical trials.
  6. Immunotherapy for patients with metastatic triple-negative inflammatory breast cancer (INCORPORATE): An international cohort study.

Conclusion:

Dr. Paola Zagami is undoubtedly a rising star in the field of oncology. Her combination of clinical experience, research accomplishments, and passion for improving cancer treatments positions her as a highly deserving candidate for the Research for Young Scientist Award. As she continues to advance her work in oncology, her future contributions have the potential to significantly impact cancer care and research globally. With some further expansion in her research focus and leadership roles, Dr. Zagami is poised to be an influential figure in oncology for years to come.

 

 

 

Vidhant Nambiar | Cancer Cell Biology | Best Researcher Award

Posted on by sciencefather

Dr. Vidhant Nambiar | Cancer Cell Biology | Best Researcher Award

Dr. Vidhant Nambiar , Fiji National University , Fiji

Dr. [Name] is currently the Acting Head of the Department of Dental Public Health, Paediatrics, and Preventive Dentistry at Fiji National University (FNU). With expertise in public health and dental care, Dr. [Name] is dedicated to improving oral health and public health across Fiji and the Pacific region. Actively involved in academic and clinical research, Dr. [Name] is the Chair of the FNU School of Dentistry and Oral Health’s Research Committee and a member of the Oral Health Pacific Island Alliance (OPIA) and the International Association of Dental Research (IADR). In addition to teaching undergraduate and postgraduate dental students, Dr. [Name] supervises research in areas like oral cancer and the effects of heat-treated cooking oils. A committed researcher and educator, Dr. [Name] also contributes to global oral health advocacy through international collaborations and presentations.

Publication Profile:

Orcid

Strengths for the Award:

  1. Innovative Research Focus: The study “Analysis of Genotoxic Oral Cancer Carcinogens in Repeatedly Heated Cooking Oils in Suva, Fiji” addresses a critical gap in oral health research, specifically the link between environmental carcinogens and oral cancer, an issue of high relevance in Fiji and the broader Pacific region.
  2. Strong Academic Foundation: The researcher holds a Master of Science in Public Health and a Bachelor of Dental Surgery with notable academic achievements. Their award-winning background and practical clinical experience underscore their ability to handle complex research.
  3. Ongoing, High-Impact Research: The study is in a randomized controlled trial phase, demonstrating rigor and potential for publication in high-impact journals. The trial also received seed funding, which reflects its importance to the broader public health community.
  4. Multidisciplinary Expertise: The researcher brings a blend of public health, clinical dentistry, and research skills to the project, offering a holistic approach to understanding health risks in the Pacific Island context.

Areas for Improvements:

  1. Expanded Collaboration: To maximize the impact of the research, future work could involve more international collaborations or partnerships with other universities or research institutes, enhancing the study’s global reach and significance.
  2. Greater Focus on Data Analysis: While the research is promising, further attention to advanced statistical analyses and more diverse data sources could provide even more robust conclusions.
  3. Wider Community Engagement: Increasing community-based research engagement and ensuring that findings are shared with local populations in accessible formats could further strengthen public health responses.

Education:

Dr. [Name] holds a Master of Science in Public Health from the University of South Wales (2021), equipping them with advanced knowledge of public health principles and practices. Prior to that, Dr. [Name] earned a Bachelor of Dental Surgery from Fiji National University (FNU), where they received the prestigious Pierre Fauchard Award in 2017. During their academic journey, Dr. [Name] gained extensive hands-on clinical experience and was exposed to cutting-edge dental technology and modern practices, including through an elective project at Melbourne and La Trobe University in 2017. This solid academic background, paired with practical dental experience, laid the foundation for their commitment to advancing oral health education, research, and policy development.

Experience:

Dr. [Name] has an extensive career in dental public health and clinical practice. As the Acting Head of the Department of Dental Public Health, Paediatrics, and Preventive Dentistry at FNU, Dr. [Name] oversees curriculum development, academic program delivery, and research activities. They have led multiple community outreach initiatives and have a demonstrated ability to manage strategic planning and research projects. Dr. [Name] has also served as a Lecturer in Dental Public Health, teaching courses across various undergraduate levels and guiding students in their research endeavors. Previous roles include managing the oral surgery clinic at CWM Hospital, where they treated complex surgical cases and participated in surgical audits. Dr. [Name] has also been integral in the COVID-19 response efforts, providing support at the Valelevu Fever Clinic and contributing to public health initiatives aimed at controlling the pandemic.

Research Focus:

Dr. [Name]’s research primarily focuses on oral health and public health, with a particular emphasis on the impact of environmental factors on oral health. Currently, they are conducting a randomized controlled trial titled “Analysis of Genotoxic Oral Cancer Carcinogens in Repeatedly Heated Cooking Oils in Suva, Fiji,” which has qualified for seed funding and is pending publication. This research aims to examine the links between oral cancer and the consumption of oils that have been repeatedly heated, a pressing issue in Pacific Island communities. Dr. [Name] is also a supervisor for research projects related to dental technology, community dentistry, and oral health prevention. Additionally, they have contributed to research on tobacco and betel nut chewing habits, publishing findings in the International Journal of Advanced Research. Their research not only aims to improve clinical practice but also has a broader public health impact, focusing on improving prevention strategies and health outcomes.

Publication Top Notes:

  • “Tobacco and Betel Nut Chewing Habits Amongst Fijians of Indian Descent Living in Suva, Fiji” 📚
  • “Analysis of Genotoxic Oral Cancer Carcinogens in Repeatedly Heated Cooking Oils in Suva, Fiji” 🔬

Conclusion:

This researcher demonstrates strong potential for the Best Researcher Award due to their innovative approach to a significant public health issue. Their current research on genotoxic carcinogens in heated cooking oils addresses an underexplored area of oral cancer prevention and risk factors, particularly in Fiji. With a solid academic background and practical experience, the researcher is well-positioned to make significant contributions to the field. Expanding collaborations, enhancing data analysis, and engaging more directly with communities could further amplify the impact of their work.